Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 05, 2024

BUY
$18.65 - $26.52 $192,971 - $274,402
10,347 New
10,347 $228,000
Q1 2022

May 06, 2022

SELL
$26.68 - $41.63 $735,781 - $1.15 Million
-27,578 Closed
0 $0
Q4 2021

Feb 03, 2022

SELL
$33.67 - $43.44 $39,764 - $51,302
-1,181 Reduced 4.11%
27,578 $1.11 Million
Q3 2021

Nov 08, 2021

SELL
$30.65 - $35.68 $16,857 - $19,624
-550 Reduced 1.88%
28,759 $939,000
Q2 2021

Aug 05, 2021

SELL
$34.33 - $44.68 $989,218 - $1.29 Million
-28,815 Reduced 49.58%
29,309 $1.01 Million
Q1 2021

May 05, 2021

SELL
$40.81 - $53.88 $1.63 Million - $2.15 Million
-39,843 Reduced 40.67%
58,124 $2.5 Million
Q4 2020

Feb 04, 2021

SELL
$36.63 - $47.63 $46,886 - $60,966
-1,280 Reduced 1.29%
97,967 $4.27 Million
Q3 2020

Nov 02, 2020

SELL
$30.09 - $43.02 $986,651 - $1.41 Million
-32,790 Reduced 24.83%
99,247 $3.85 Million
Q2 2020

Aug 05, 2020

BUY
$27.76 - $33.42 $683,812 - $823,234
24,633 Added 22.93%
132,037 $4.28 Million
Q1 2020

May 04, 2020

BUY
$20.69 - $37.79 $785,185 - $1.43 Million
37,950 Added 54.64%
107,404 $3.21 Million
Q4 2019

Feb 07, 2020

BUY
$32.75 - $41.43 $2.27 Million - $2.88 Million
69,454 New
69,454 $2.39 Million
Q3 2019

Nov 07, 2019

SELL
$33.73 - $46.27 $904,267 - $1.24 Million
-26,809 Closed
0 $0
Q2 2019

Jul 29, 2019

BUY
$29.6 - $40.93 $311,392 - $430,583
10,520 Added 64.58%
26,809 $1.1 Million
Q1 2019

Apr 25, 2019

BUY
$27.85 - $38.09 $263,711 - $360,674
9,469 Added 138.84%
16,289 $506,000
Q3 2018

Nov 05, 2018

SELL
$35.69 - $47.65 $23,198 - $30,972
-650 Reduced 8.7%
6,820 $266,000
Q2 2018

Jul 31, 2018

SELL
$28.41 - $42.41 $89,491 - $133,591
-3,150 Reduced 29.66%
7,470 $276,000
Q4 2017

Feb 05, 2018

SELL
$19.29 - $24.83 $276,155 - $355,466
-14,316 Reduced 57.41%
10,620 $233,000
Q3 2017

Nov 06, 2017

BUY
$19.61 - $23.35 $488,994 - $582,255
24,936
24,936 $572,000

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.43B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.